Coverage clusters in markets, which accounts for 4 of those 5, with the remainder spread across 1 other category. BTIG Research is most often covered alongside Wall Street Zen, which appears in 4 of these 5 stories. Against the same-window beat baseline of 27% negative, this entity's 0% share is less negative.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about BTIG Research
Coverage clusters in markets, which accounts for 4 of those 5, with the remainder spread across 1 other category. BTIG Research is most often covered alongside Wall Street Zen, which appears in 4 of these 5 stories. Against the same-window beat baseline of 27% negative, this entity's 0% share is less negative. At 5, the average consequence score sits below the same-window beat average of 6.2. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window. Across a 173-day span, the pace is roughly 0.2 stories per week. This profile follows 5 Finance stories mentioning BTIG Research across the period from March 5, 2026 to August 24, 2026.
Stories tracked
5
Per week
0.2
Negative
0%
Sources per story
2
Computed from the 5 stories linked to this entity, with beat comparisons drawn from all 3495 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering BTIG Research. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen issued divergent ratings on two energy names, cutting T1 Energy to Strong Sell while lifting SM Energy to Strong Buy. T1 trades at $4.45 with negative P/E and 3.5 D/E, while SM offers a 7.35 P/E and 0.85 D/E. The split highlights a rotation from leveraged loss-makers to cash-flow-positive mid-cap energy.
Wall Street Zen lifted Amplify Energy to Hold from Strong Sell on August 16, with shares at $4.78 and a $9 consensus target. Thin coverage and insider buying make the upgrade a key sentiment shift for a $198 million small-cap energy name.
Wall Street Zen downgraded both Oceaneering International and Klaviyo from Buy to Hold, spotlighting two $5 billion market-cap companies with vastly different P/E ratios—14.59 for OII and 895.95 for KVYO. The ratings actions come as consensus targets diverge from current prices.
In a single day, Wall Street Zen downgraded CME Group to strong sell, and Novavax and SNDL to sell, sending bearish signals across exchanges, biotech, and cannabis. Markets digest the calls amid wide analyst disagreement.
Guidewire Software reported Q4 CY2025 sales that topped analyst estimates, providing a strong rebuttal to recent analyst downgrades and insider selling concerns. The results highlight the accelerating adoption of Guidewire Cloud, bolstered by major international deals like the Sompo Group expansion.
BTIG Research is linked from 5 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.